128 related articles for article (PubMed ID: 8514281)
1. Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells.
Jørgensen N; Giwercman A; Müller J; Skakkebaek NE
Histopathology; 1993 Apr; 22(4):373-8. PubMed ID: 8514281
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells.
Jørgensen N; Müller J; Jaubert F; Clausen OP; Skakkebaek NE
Histopathology; 1997 Feb; 30(2):177-86. PubMed ID: 9190360
[TBL] [Abstract][Full Text] [Related]
3. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.
Jørgensen N; Rajpert-De Meyts E; Graem N; Müller J; Giwercman A; Skakkebaek NE
Lab Invest; 1995 Feb; 72(2):223-31. PubMed ID: 7531795
[TBL] [Abstract][Full Text] [Related]
4. DNA content and expression of tumour markers in germ cells adjacent to germ cell tumours in childhood: probably a different origin for infantile and adolescent germ cell tumours.
Jørgensen N; Müller J; Giwercman A; Visfeldt J; Møller H; Skakkebaek NE
J Pathol; 1995 Jul; 176(3):269-78. PubMed ID: 7674089
[TBL] [Abstract][Full Text] [Related]
5. Double immunolabeling by the RBM and the PLAP markers for identifying intratubular (in situ) germ cell neoplasia of the testis.
Schreiber L; Lifschitz-Mercer B; Paz G; Yavetz H; Elliott DJ; Kula K; Slowikowska-Hilczer J; Maymon BB
Int J Surg Pathol; 2003 Jan; 11(1):17-20. PubMed ID: 12598912
[TBL] [Abstract][Full Text] [Related]
6. Lack of RBM expression as a marker for carcinoma in situ of prepubertal dysgenetic testis.
Schreiber L; Lifschitz-Mercer B; Paz G; Yavetz H; Zadik Z; Kula K; Slowikowska-Hilczer J; Rey R; Elliott DJ; Maymon BB
J Androl; 2003; 24(1):78-84. PubMed ID: 12514087
[TBL] [Abstract][Full Text] [Related]
7. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
[TBL] [Abstract][Full Text] [Related]
8. Cryptorchidism and testis cancer. Atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood.
Müller J; Skakkebaek NE; Nielsen OH; Graem N
Cancer; 1984 Aug; 54(4):629-34. PubMed ID: 6146398
[TBL] [Abstract][Full Text] [Related]
9. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F.
Giwercman A; Cantell L; Marks A
APMIS; 1991 Jul; 99(7):586-94. PubMed ID: 2069800
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody 43-9F as a sensitive immunohistochemical marker of carcinoma in situ of human testis.
Giwercman A; Lindenberg S; Kimber SJ; Andersson T; Müller J; Skakkebaek NE
Cancer; 1990 Mar; 65(5):1135-42. PubMed ID: 2406007
[TBL] [Abstract][Full Text] [Related]
11. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.
Honecker F; Stoop H; de Krijger RR; Chris Lau YF; Bokemeyer C; Looijenga LH
J Pathol; 2004 Jul; 203(3):849-57. PubMed ID: 15221945
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody 43-9F: an immunohistochemical marker of embryonal carcinoma of the testis.
Visfeldt J; Giwercman A; Skakkebaek NE
APMIS; 1992 Jan; 100(1):63-70. PubMed ID: 1536722
[TBL] [Abstract][Full Text] [Related]
13. Expression of FGFR3 during human testis development and in germ cell-derived tumours of young adults.
Ewen KA; Olesen IA; Winge SB; Nielsen AR; Nielsen JE; Graem N; Juul A; Rajpert-De Meyts E
Int J Dev Biol; 2013; 57(2-4):141-51. PubMed ID: 23784824
[TBL] [Abstract][Full Text] [Related]
14. Adult immunohistochemical markers fail to detect intratubular germ cell neoplasia in prepubertal boys with cryptorchidism.
Kvist K; Clasen-Linde E; Cortes D; Petersen BL; Thorup J
J Urol; 2014 Apr; 191(4):1084-9. PubMed ID: 24095908
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining of germ cell tumors and intratubular malignant germ cells of the testis using antibody to placental alkaline phosphatase and a monoclonal anti-seminoma antibody.
Bailey D; Marks A; Stratis M; Baumal R
Mod Pathol; 1991 Mar; 4(2):167-71. PubMed ID: 1646453
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
Cancer; 1996 Nov; 78(9):1958-66. PubMed ID: 8909317
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis.
Giwercman A; Andrews PW; Jørgensen N; Müller J; Graem N; Skakkebaek NE
Cancer; 1993 Aug; 72(4):1308-14. PubMed ID: 8339218
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma in situ of the testis: review of biological and clinical features.
Dieckmann KP; Skakkebaek NE
Int J Cancer; 1999 Dec; 83(6):815-22. PubMed ID: 10597201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
